by Annie De Groot | Nov 1, 2013 | Events
We are pleased to announce that EpiVax is hosting the “Tregitope Europe” meeting in conjunction with the 9th International Congress on Autoimmunity in Nice, France on March 26th 2014. The meeting will consist of a 120 minute scientific session as part of...
by Annie De Groot | Jul 26, 2013 | News
A Brand New EpiVax Publication is Now Online! Modulation of CD8+ T cell responses to AAV vectors with IgG-derived MHC class II epitopes (Tregitopes) Immune responses directed against viral capsid proteins constitute a main safety concern in the use of...
by Annie De Groot | Apr 19, 2013 | Thinking Out Loud -Blog
H7N9 is not pandemic yet, but there is ‘heightened’ concern Numerous reports are describing the heightened concern of a potential pandemic situation occurring in China. Total number of verified cases up to 91, with the death toll still at 17, there were 87...
by Annie De Groot | Nov 1, 2012 | News, Thinking Out Loud -Blog
Providence, RI – Providence-based biotech company EpiVax, Inc. was awarded a new $55,000 grant from the GBS-CIDP Foundation International, to explore using Tregitopes as a novel immuno-modulator therapy for a nerve disease that is currently treated with...
by Annie De Groot | May 12, 2012 | News, Thinking Out Loud -Blog
¡Hola! from Granada, Spain! As it turns out, there are as many kinds of Tregs as there are types of tapas in Granada. But there is only one Tregitope. OK, make that several (in fact, there are six that we aim to use for Tregitope therapy in autoimmune disease)....
